Delivery Order 75N95023D00021-75N95025F00001
Award Date
6/25/25
Potential Completion Date
6/24/26
Potential Value
$133K
Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Peters, MO 63304, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...
This is a task order award under the National Institute on Drug Abuse's (NIDA) IDIQ contract No. HHSN271201800024I for receptor binding and predictive toxicology services. The award, valued at $291,884.01, was issued to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The task order is for work described under the NIDA contract with a period of performance from April 3, 2020 to April 2, 2021. The contract was awarded on a firm-fixed-price...
This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
This is a $142,193 cost-plus-fixed-fee task order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The task order is for receptor binding and predictive toxicology services to support drug discovery research, with a period of performance from September 26, 2023 to September 25, 2024. Eurofins...
The U.S. National Institute on Drug Abuse (NIDA) has awarded a firm-fixed-price purchase order contract worth $20,217.10 to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract, which does not have a set-aside designation, is for the provision of various research and development services to support NIDA's drug abuse research programs. These services include receptor binding studies, predictive toxicology, safety pharmacology, and non-clinical research....
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
This is a $723,710.98 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for non-clinical and laboratory support services and has a period of performance through September 2028. The contract is not associated with a specific set-aside program. Eurofins Discovery Services North America, LLC holds several multi-million dollar...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $26,769.20 firm fixed-price purchase order is for the provision of PathHunter detection kit reagent, item #93-0001L, to support the HEAL (Helping to End Addiction Long-term) initiative's medicinal chemistry research to improve potency and selectivity of dopamine...
This is a $20,823.14 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to Eurofins Discoverx LLC, a foreign-owned for-profit organization. The purpose is to test 30 compounds for binding to IRAK and FLT3 kinases over a 1-year period of performance from September 16, 2020 to September 15, 2021. This award was made through a non-competitive combined synopsis/solicitation process under simplified acquisition procedures...